The literature, infective endocarditis in patients with hypertrophic cardiomyopathy is virtually limited to isolated reported cases or groups of cases, therefore the risk of infective endocarditis during HCM remains poorly defined. It is considered low and mostly limited to patients with a subaortic obstruction or with an intrinsic mitral defect